Neuropsychological assessment protocol in an ongoing randomized controlled trial on posterior subthalamic area vs. ventral intermediate nucleus deep brain stimulation for essential tremor
Metadatos
Mostrar el registro completo del ítemAutor
Triguero Cueva, Lucía; Marín Romero, Bartolomé; Madrid Navarro, Carlos Javier; Pérez Navarro, Maria José; Iáñez Velasco, Benjamín; Mínguez Castellanos, Adolfo; Jouma Katati, Majed; Escamilla-Sevilla, FranciscoEditorial
Frontiers Media
Materia
cognitive-affective impairment deep brain stimulation essential tremor
Fecha
2023-10-30Referencia bibliográfica
Triguero-Cueva L, Marín-Romero B, Madrid-Navarro CJ, Pérez-Navarro MJ, Iáñez-Velasco B, Mínguez-Castellanos A, Katati MJ and Escamilla-Sevilla F (2023) Neuropsychological assessment protocol in an ongoing randomized controlled trial on posterior subthalamic area vs. ventral intermediate nucleus deep brain stimulation for essential tremor. Front. Neurol. 14:1222592. doi: 10.3389/fneur.2023.1222592
Patrocinador
Instituto de Salud Carlos III; European Regional Development Fund (PI19/01571)Resumen
Objective: Patients with essential tremor (ET) may experience cognitive-affective
impairment. Deep brain stimulation (DBS) of different targets, such as the ventral
intermediate nucleus (VIM) of the thalamus or the posterior subthalamic area
(PSA), has been shown to be beneficial for refractory ET. However, there is little
evidence regarding the possible neuropsychological effects of PSA-DBS on
patients with ET, and there are few studies comparing it with VIM-DBS in this
population.
In this study, we aim to present the evaluation protocol and neuropsychological
battery as used in an ongoing trial of DBS for ET comparing the already mentioned
targets.
Methods: As part of a randomized, double-blind, crossover clinical trial comparing
the effectiveness and safety of PSA-DBS vs. VIM-DBS, 11 patients with refractory
ET will undergo a multi-domain neuropsychological battery assessment. This will
include a pre−/post-implantation assessment (3 months after the stimulation of
each target and 6 months after an open stage of DBS on the most optimal target).
Conclusion: Evidence on the neuropsychological effects of DBS in patients
with refractory ET is very scarce, particularly in lesser-explored targets such
as PSA. This study could contribute significantly in this field, particularly on
pre-procedure safety analysis for tailored patient/technique selection, and to
complete the safety analysis of the procedure. Moreover, if proven useful, this
proposed neuropsychological assessment protocol could be extensible to other
surgical therapies for ET.